While some peptides may support immune regulation, the KLOW blend is primarily designed to support healing, recovery, inflammation management, and tissue repair
Research suggests BPC-157 may modulate NO production in a way that supports tissue repair rather than exacerbating inflammation
declares having received consulting honoraria from Altimmune, Amgen, Esperion, Merck, MJH Life Sciences, Novartis and Novo Nordisk
Pulsed electromagnetic field therapy paired with red light to stimulate cellular repair, reduce inflammation, and accelerate recovery
Substantial published clinical research from Metabolic Pharmaceuticals' formal pharmaceutical development program (Phase 1, 2, and IIb trials)